Mitochondrial Cocktail for Gulf War Illness

Beyond Benefits of Q10: Mitochondrial Cocktail for Gulf War Illness

The purpose of this study is to develop preliminary evidence, such as effect size and variance estimates, to guide successful conduct of a properly-powered clinical trial to assess the benefit of a mitochondrial cocktail (incorporating individualization of treatment) in Gulf War illness (GWI).

See below.

Inclusion Criteria:

• Meet symptom criteria for Gulf War illness with BOTH the Centers for Disease Control and Prevention (CDC) Criteria (persistent symptoms in at least 2 of 3 designated symptom domains of fatigue/sleep, mood/cognition, and musculoskeletal) and Kansas Criteria (score a moderate or severe rating in at least 3 of the 6 symptom domains of fatigue, pain, neurological/cognitive/mood, skin, GI and respiratory).

Exclusion Criteria:

• Have conditions like multiple sclerosis or lupus that can produce similar symptoms and be confused for Gulf War illness.
• Participating in a concurrent treatment trial.
• Unwilling or unable to comply with the treatment protocol
• Failed run-in; do not take at least 80% of run-in medications